Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Brazilian Presidential Decree Opens Door To Less Stringent GMP Certification Requirements For Foreign Firms

This article was originally published in The Gray Sheet

Executive Summary

New decree opens door to more lenient good manufacturing practice certification requirements than are currently imposed on international medical device manufacturers seeking to gain market entry in Brazil.

You may also be interested in...

FDA, Global Partners Prepare To Ramp Up Single-Audit Program

FDA is strongly encouraging manufacturers to participate in the Medical Device Single Audit Program, set to launch in a pilot phase by June. An agency official points to strong global incentives, particularly for firms pursuing the Brazil and Canada markets.

Accelerating China, Covidien Establishes JV With Changzhou Kangdi

Irish device maker Covidien has set up a joint venture with Changzhou Kangdi to capture the value segment in China’s vast lower-tier market.

Covidien Taps Local Players In China, Brazil To Reach Public Hospital Markets

Covidien acquired a privately held manufacturer of electrosurgical generators based in Ribeirao Preto, Brazil, and established a joint venture with a manufacturer of open stapler products based in Kiangsu Province in China, to access patients who can’t afford top-tier hospitals in those countries.

Related Content


Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts